समाचार में क्यों
- The Department of Pharmaceuticals has extended the Production Linked Incentive Scheme for Medical Devices (PLI-MD) up to FY 2035–36 and invited fresh applications.
- Operational guidelines were modified to eliminate minimum sales thresholds and reduce investment requirements to improve ease of doing business.
मुख्य शब्द
PLI Scheme
A financial incentive scheme offering performance-linked rewards based on incremental sales from domestic production.
Target Segments (TS)
Classified categories of medical equipment and components designated for specific financial incentives.
Minimum Sales Threshold
A mandatory revenue baseline previously required before an applicant could qualify to receive incentive payouts.
Department of Pharmaceuticals
The administrative body under the Ministry of Chemicals and Fertilizers managing pharmaceutical and medical device manufacturing policies.
What is the PLI-MD Scheme?
- Launched in FY 2020–21 by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, to promote domestic manufacturing of medical devices and reduce import dependence.
- Covers four Target Segments: medical consumables/disposables/implants (TS 1), critical components (TS 2), high-end devices at nascent stages (TS 3), and assembled high-end devices (TS 4).
Key operational changes
- Scheme tenure extended up to FY 2035–36 with an available outlay of approximately Rs 2,700 crore.
- Minimum Sales Threshold requirement to claim incentives has been completely discontinued.
- Minimum Investment Requirement trimmed to lower capital entry barriers for component manufacturers.
- Applicants allowed a baseline gestation period of 3 years for establishing manufacturing facilities across all target segments.
Why it matters
- Shifts policy focus from finished equipment assembly to local critical component manufacturing (such as X-ray tubes, MRI magnets, LINAC components).
- Improves viability for domestic med-tech MSMEs by decoupling financial disbursements from mandatory revenue milestones.
प्रीलिम्स तथ्य
- PLI-MD covers 4 target segments ranging from consumables to critical component manufacturing.
- Minimum sales threshold requirement for claiming incentive under PLI-MD has been removed.
मेंस चर्चा
- Role of targeted production incentives in curbing critical medical equipment import dependence.
- Impact of simplifying compliance norms on boosting capital investment in domestic med-tech research and development.
स्रोत: PIB
समान विषय · पिछले पेपर
UPSC ने यह पहले भी पूछा है
ये पिछले वर्षों के प्रश्न उसी विषय पर हैं। अभ्यास के लिए खोलें।